EXELIXIS, INC. (EXEL)

Data as of Aug 12, 2026, from SEC Form 4 filings.

Net insider selling (90d)Watch EXEL

See up to 3 months of EXEL. The 7-day demo opens the 1M and 3M ranges and puts EXEL on your watchlist.

Latest EXEL insider trades

Mary C. Beckerle - Director
Open-market sale$527K
Aug 10, 2026
Jack L. Wyszomierski - Director
Open-market sale$198K

About EXELIXIS, INC. (EXEL)

EXELIXIS, INC. is an SEC registrant, filing under CIK 0000939767, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.

Sector: Health Care

SEC filings for EXEL on EDGAR

EXEL Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market sale	1	9,812	$527K

EXEL insider transactions (Form 4)

77 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 2 of 3.

Date	Insider	Transaction	Security	Shares	Price	Value
Feb 19, 2026	Dana Aftab - Officer	Open-market sale	Common Stock	29,873	$44.35	$1.32M
Feb 18, 2026	Jack L. Wyszomierski - Director	Option exercise	Common Stock	20,634	$19.77	$408K
Feb 18, 2026	Jack L. Wyszomierski - Director	Open-market sale	Common Stock	99,574	$44.01^{footnote F3}	$4.38M
Feb 18, 2026	Jack L. Wyszomierski - Director	Option exercise	Option (right to buy)	20,634	$0.00	-
Footnote F3 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.32 to $44.49. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Feb 17, 2026	Julie Smith - Director	Option exercise	Common Stock	42,422	$18.19	$772K
Feb 17, 2026	Julie Smith - Director	Open-market sale	Common Stock	42,422	$43.33^{footnote F2}	$1.84M
Feb 18, 2026	Julie Smith - Director	Option exercise	Common Stock	44,087	$19.39	$855K
Feb 18, 2026	Julie Smith - Director	Open-market sale	Common Stock	44,087	$44.50	$1.96M
Feb 18, 2026	Julie Smith - Director	Option exercise	Common Stock	20,030	$21.69	$434K
Feb 18, 2026	Julie Smith - Director	Open-market sale	Common Stock	20,030	$44.30	$887K
Feb 17, 2026	Julie Smith - Director	Option exercise	Option (right to buy)	42,422	$0.00	-
Feb 18, 2026	Julie Smith - Director	Option exercise	Option (right to buy)	44,087	$0.00	-
Feb 18, 2026	Julie Smith - Director	Option exercise	Option (right to buy)	20,030	$0.00	-
Footnote F2 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $44.30 to $44.44. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Feb 13, 2026	Christopher J. Senner - Officer	Open-market sale	Common Stock	34,278	$43.00^{footnote F1}	$1.47M
Feb 15, 2026	Christopher J. Senner - Officer	Tax withholding / forfeiture	Common Stock	35,870^{footnote F3}	$43.92	$1.58M
Feb 17, 2026	Christopher J. Senner - Officer	Open-market sale	Common Stock	30,617	$43.67^{footnote F4}	$1.34M
Footnote F1 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.00 to $43.04. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR Footnote F3 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January… Full note on SEC EDGAR Footnote F4 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.66 to $43.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Feb 15, 2026	Patrick J. Haley - Officer	Tax withholding / forfeiture	Common Stock	31,483^{footnote F1}	$43.92	$1.38M
Feb 17, 2026	Patrick J. Haley - Officer	Open-market sale	Common Stock	3,036	$43.84^{footnote F3}	$133K
Feb 17, 2026	Patrick J. Haley - Officer	Open-market sale	Common Stock	64,778	$43.50^{footnote F4}	$2.82M
Footnote F1 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January… Full note on SEC EDGAR Footnote F3 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.80 to $43.84. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR Footnote F4 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.50 to $43.64. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Feb 13, 2026	Michael Morrissey - Officer	Option exercise	Common Stock	494,700	$21.31	$10.54M
Feb 13, 2026	Michael Morrissey - Officer	Tax withholding / forfeiture	Common Stock	369,606^{footnote F2}	$43.92	$16.23M
Feb 15, 2026	Michael Morrissey - Officer	Tax withholding / forfeiture	Common Stock	120,390^{footnote F3}	$43.92	$5.29M
Feb 17, 2026	Michael Morrissey - Officer	Gift	Common Stock	250,736	$0.00	-
Feb 17, 2026	Michael Morrissey - Officer	Gift	Common Stock	250,736	$0.00	-
Feb 18, 2026	Michael Morrissey - Officer	Gift	Common Stock	125,094	$0.00	-
Feb 18, 2026	Michael Morrissey - Officer	Gift	Common Stock	125,094	$0.00	-
Feb 13, 2026	Michael Morrissey - Officer	Option exercise	Option (right to buy)	494,700	$0.00	-
Footnote F2 (shares): Represents a "net exercise" of an outstanding stock option to purchase 494,700 shares, and pursuant to which the Reporting Person received 125,094 shares of Common Stock. The Issuer withheld 369,606 shares of Common Stock underlying the stock option for payment of the exercise… Full note on SEC EDGAR Footnote F3 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January… Full note on SEC EDGAR
Feb 13, 2026	Sue Gail Eckhardt - Director	Open-market sale	Common Stock	3,856	$43.79^{footnote F2}	$169K
Footnote F2 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.89 to $43.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Feb 15, 2026	Dana Aftab - Officer	Tax withholding / forfeiture	Common Stock	26,485^{footnote F1}	$43.92	$1.16M
Feb 15, 2026	Dana Aftab - Officer	Tax withholding / forfeiture	Common Stock	12,720^{footnote F3}	$43.92	$559K
Footnote F1 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January… Full note on SEC EDGAR Footnote F3 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of RSUs awarded on January 5, 2023.
Feb 13, 2026	Bob Oliver - Director	Option exercise	Common Stock	9,088	$19.28	$175K
Feb 13, 2026	Bob Oliver - Director	Open-market sale	Common Stock	9,088	$43.61	$396K
Feb 13, 2026	Bob Oliver - Director	Open-market sale	Common Stock	21,162	$43.90^{footnote F2}	$929K
Feb 13, 2026	Bob Oliver - Director	Option exercise	Option (right to buy)	9,088	$0.00	-
Footnote F2 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.90 to $43.96. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Feb 15, 2026	Brenda Hefti - Officer	Tax withholding / forfeiture	Common Stock	5,430^{footnote F1}	$43.92	$238K
Feb 18, 2026	Brenda Hefti - Officer	Open-market sale	Common Stock	18,669	$44.01^{footnote F4}	$822K
Footnote F1 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January… Full note on SEC EDGAR Footnote F4 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.32 to $44.49. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Jan 15, 2026	Michael Morrissey - Officer	Grant or award	Common Stock	548,073^{footnote F2}	$0.00	-
Jan 15, 2026	Michael Morrissey - Officer	Tax withholding / forfeiture	Common Stock	139,524^{footnote F4}	$45.23	$6.31M
Footnote F2 (shares): On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's… Full note on SEC EDGAR Footnote F4 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026.
Jan 15, 2026	Dana Aftab - Officer	Grant or award	Common Stock	119,578^{footnote F2}	$0.00	-
Jan 15, 2026	Dana Aftab - Officer	Tax withholding / forfeiture	Common Stock	27,254^{footnote F4}	$45.23	$1.23M
Footnote F2 (shares): On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's… Full note on SEC EDGAR Footnote F4 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026.
Jan 15, 2026	Patrick J. Haley - Officer	Grant or award	Common Stock	139,508^{footnote F2}	$0.00	-
Jan 15, 2026	Patrick J. Haley - Officer	Tax withholding / forfeiture	Common Stock	32,332^{footnote F4}	$45.23	$1.46M
Footnote F2 (shares): On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's… Full note on SEC EDGAR Footnote F4 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026.
Jan 15, 2026	Christopher J. Senner - Officer	Grant or award	Common Stock	149,474^{footnote F2}	$0.00	-
Jan 15, 2026	Christopher J. Senner - Officer	Tax withholding / forfeiture	Common Stock	40,459^{footnote F4}	$45.23	$1.83M
Footnote F2 (shares): On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's… Full note on SEC EDGAR Footnote F4 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026.
Nov 25, 2025	David Edward Johnson - Director	Open-market purchase	Common Stock	27,532	$43.12	$1.19M
Nov 20, 2025	Patrick J. Haley - Officer	Open-market sale	Common Stock	10,000	$42.11^{footnote F1}	$421K
Nov 20, 2025	Patrick J. Haley - Officer	Open-market sale	Common Stock	23,539	$41.93^{footnote F3}	$987K
Nov 20, 2025	Patrick J. Haley - Officer	Open-market sale	Common Stock	10,648	$41.77^{footnote F4}	$445K
Nov 21, 2025	Patrick J. Haley - Officer	Open-market sale	Common Stock	28,043	$42.58^{footnote F5}	$1.19M
Footnote F1 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.10 to $42.13. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR Footnote F3 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.87 to $41.99. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR Footnote F4 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.77 to $41.79. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR Footnote F5 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.51 to $42.71. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Nov 21, 2025	Dana Aftab - Officer	Gift	Common Stock	24,000	$0.00	-
Nov 17, 2025	Bob Oliver - Director	Gift	Common Stock	1,044	$0.00	-
Nov 12, 2025	Stelios Papadopoulos - Director	Open-market sale	Common Stock	100,000	$43.55^{footnote F1}	$4.36M
Footnote F1 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.55 to $43.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Nov 11, 2025	Michael Morrissey - Officer	Gift	Common Stock	160,000	$0.00	-
Nov 12, 2025	Michael Morrissey - Officer	Gift	Common Stock	101,548	$0.00	-
Nov 12, 2025	Michael Morrissey - Officer	Gift	Common Stock	101,548	$0.00	-
Nov 12, 2025	Michael Morrissey - Officer	Gift	Common Stock	80,000	$0.00	-
Nov 11, 2025	Dana Aftab - Officer	Open-market sale	Common Stock	48,383	$42.50^{footnote F1}	$2.06M
Footnote F1 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Nov 11, 2025	Mary C. Beckerle - Director	Option exercise	Option (right to buy)	5,784	$0.00	-
Nov 11, 2025	Mary C. Beckerle - Director	Option exercise	Common Stock	5,784	$23.24	$134K
Nov 11, 2025	Mary C. Beckerle - Director	Open-market sale	Common Stock	5,784	$42.03	$243K
Nov 11, 2025	Mary C. Beckerle - Director	Open-market sale	Common Stock	18,838	$41.90^{footnote F2}	$789K
Footnote F2 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.81 to $42.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Oct 8, 2025	Dana Aftab - Officer	Grant or award	Common Stock	50,673^{footnote F1}	$0.00	-
Footnote F1 (shares): Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity… Full note on SEC EDGAR
Jun 3, 2025	Jack L. Wyszomierski - Director	Open-market sale	Common Stock	7,535	$43.09	$325K
May 29, 2025	Stelios Papadopoulos - Director	Grant or award	Common Stock	9,812	$0.00	-
May 29, 2025	George Poste - Director	Grant or award	Common Stock	9,812	$0.00	-
May 29, 2025	Jack L. Wyszomierski - Director	Grant or award	Common Stock	9,812	$0.00	-
May 16, 2025	George Poste - Director	Option exercise	Common Stock	20,634	$19.77	$408K
May 16, 2025	George Poste - Director	Open-market sale	Common Stock	20,634	$45.99	$949K
May 16, 2025	George Poste - Director	Option exercise	Option (right to buy)	20,634	$0.00	-
May 15, 2025	Stelios Papadopoulos - Director	Option exercise	Common Stock	20,634	$19.77	$408K
May 15, 2025	Stelios Papadopoulos - Director	Open-market sale	Common Stock	20,634	$44.35	$915K
May 15, 2025	Stelios Papadopoulos - Director	Option exercise	Common Stock	15,874	$20.50	$325K
May 15, 2025	Stelios Papadopoulos - Director	Open-market sale	Common Stock	15,874	$44.35	$704K
May 15, 2025	Stelios Papadopoulos - Director	Option exercise	Option (right to buy)	20,634	$0.00	-
May 15, 2025	Stelios Papadopoulos - Director	Option exercise	Option (right to buy)	15,874	$0.00	-
May 14, 2025	Michael Morrissey - Officer	Option exercise	Common Stock	308,365	$18.80	$5.80M
May 14, 2025	Michael Morrissey - Officer	Tax withholding / forfeiture	Common Stock	220,494	$44.65	$9.85M
May 15, 2025	Michael Morrissey - Officer	Tax withholding / forfeiture	Common Stock	104,769	$44.65	$4.68M
May 16, 2025	Michael Morrissey - Officer	Gift	Common Stock	87,871	$0.00	-
May 16, 2025	Michael Morrissey - Officer	Gift	Common Stock	87,871	$0.00	-
May 14, 2025	Michael Morrissey - Officer	Option exercise	Option (right to buy)	308,365	$0.00	-

Recent EXEL Form 8-K filings

Read EXEL company news

Sep 11, 2026Item 8.01

Read the filing on SEC EDGAR

Aug 31, 2026Item 8.01

Read the filing on SEC EDGAR

Aug 5, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

May 29, 2026Item 5.02, 5.07, 9.01

Read the filing on SEC EDGAR

Recent EXEL Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Aug 10, 2026	MARY BECKERLE	Director	9,812	$526K	View on EDGAR
Jun 1, 2026	-	-	-	-

EXEL insider trading FAQ

What is the latest insider trade for EXEL?

EXELIXIS, INC. (EXEL) had 1 insider filing in the last 90 days, with the most recent on 2026-08-12. The full record for EXEL runs to 77 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying EXEL stock?

No insider purchases of EXEL were filed in the last 90 days. 1 purchase is on record for this company.

How many insiders are selling EXEL stock?

1 insider sale of EXEL was filed in the last 90 days, totaling $527K.

Where can I see EXEL SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects EXEL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Aug 12, 2026 - Mary C. Beckerle view on EDGAR
Jun 3, 2026 - Jack L. Wyszomierski view on EDGAR
Jun 3, 2026 - Sue Gail Eckhardt view on EDGAR
May 29, 2026 - Stelios Papadopoulos view on EDGAR
May 29, 2026 - Tomas J. Heyman view on EDGAR
May 29, 2026 - Sue Gail Eckhardt view on EDGAR
May 29, 2026 - Julie Smith view on EDGAR
May 29, 2026 - Maria C. Freire view on EDGAR
May 29, 2026 - Mary C. Beckerle view on EDGAR

Related companies with recent insider activity

Learn more

Insider selling: signal or noise?: Why most insider sales are routine, and the few patterns worth a second look.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where EXEL's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow EXEL with a 7-day demo

EXEL on your watchlist
Every EXEL Form 4 filing on record
Up to 3 months of EXEL price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market sale

9,812

$527K

Date

Insider

Transaction

Security

Price

Value

Feb 19, 2026

Dana Aftab - Officer

Open-market sale

Common Stock

29,873

$44.35

$1.32M

Feb 18, 2026

Jack L. Wyszomierski - Director

Option exercise

Common Stock

20,634

$19.77

$408K

Feb 18, 2026

Jack L. Wyszomierski - Director

Open-market sale

Common Stock

99,574

$44.01^{footnote F3}

$4.38M

Feb 18, 2026

Jack L. Wyszomierski - Director

Option exercise

Option (right to buy)

20,634

$0.00

Footnote F3 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.32 to $44.49. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR

Feb 17, 2026

Julie Smith - Director

Option exercise

Common Stock

42,422

$18.19

$772K

Feb 17, 2026

Julie Smith - Director

Open-market sale

Common Stock

42,422

$43.33^{footnote F2}

$1.84M

Feb 18, 2026

Julie Smith - Director

Option exercise

Common Stock

44,087

$19.39

$855K

Feb 18, 2026

Julie Smith - Director

Open-market sale

Common Stock

44,087

$44.50

$1.96M

Feb 18, 2026

Julie Smith - Director

Option exercise

Common Stock

20,030

$21.69

$434K

Feb 18, 2026

Julie Smith - Director

Open-market sale

Common Stock

20,030

$44.30

$887K

Feb 17, 2026

Julie Smith - Director

Option exercise

Option (right to buy)

42,422

$0.00

Feb 18, 2026

Julie Smith - Director

Option exercise

Option (right to buy)

44,087

$0.00

Feb 18, 2026

Julie Smith - Director

Option exercise

Option (right to buy)

20,030

$0.00

Footnote F2 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $44.30 to $44.44. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR

Feb 13, 2026

Christopher J. Senner - Officer

Open-market sale

Common Stock

34,278

$43.00^{footnote F1}

$1.47M

Feb 15, 2026

Christopher J. Senner - Officer

Tax withholding / forfeiture

Common Stock

35,870^{footnote F3}

$43.92

$1.58M

Feb 17, 2026

Christopher J. Senner - Officer

Open-market sale

Common Stock

30,617

$43.67^{footnote F4}

$1.34M

Footnote F1 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.00 to $43.04. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F3 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January… Full note on SEC EDGAR
Footnote F4 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.66 to $43.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR

Feb 15, 2026

Patrick J. Haley - Officer

Tax withholding / forfeiture

Common Stock

31,483^{footnote F1}

$43.92

$1.38M

Feb 17, 2026

Patrick J. Haley - Officer

Open-market sale

Common Stock

3,036

$43.84^{footnote F3}

$133K

Feb 17, 2026

Patrick J. Haley - Officer

Open-market sale

Common Stock

64,778

$43.50^{footnote F4}

$2.82M

Footnote F1 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January… Full note on SEC EDGAR
Footnote F3 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.80 to $43.84. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F4 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.50 to $43.64. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR

Feb 13, 2026

Michael Morrissey - Officer

Option exercise

Common Stock

494,700

$21.31

$10.54M

Feb 13, 2026

Michael Morrissey - Officer

Tax withholding / forfeiture

Common Stock

369,606^{footnote F2}

$43.92

$16.23M

Feb 15, 2026

Michael Morrissey - Officer

Tax withholding / forfeiture

Common Stock

120,390^{footnote F3}

$43.92

$5.29M

Feb 17, 2026

Michael Morrissey - Officer

Gift

Common Stock

250,736

$0.00

Feb 17, 2026

Michael Morrissey - Officer

Gift

Common Stock

250,736

$0.00

Feb 18, 2026

Michael Morrissey - Officer

Gift

Common Stock

125,094

$0.00

Feb 18, 2026

Michael Morrissey - Officer

Gift

Common Stock

125,094

$0.00

Feb 13, 2026

Michael Morrissey - Officer

Option exercise

Option (right to buy)

494,700

$0.00

Footnote F2 (shares): Represents a "net exercise" of an outstanding stock option to purchase 494,700 shares, and pursuant to which the Reporting Person received 125,094 shares of Common Stock. The Issuer withheld 369,606 shares of Common Stock underlying the stock option for payment of the exercise… Full note on SEC EDGAR
Footnote F3 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January… Full note on SEC EDGAR

Feb 13, 2026

Sue Gail Eckhardt - Director

Open-market sale

Common Stock

3,856

$43.79^{footnote F2}

$169K

Footnote F2 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.89 to $43.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR

Feb 15, 2026

Dana Aftab - Officer

Tax withholding / forfeiture

Common Stock

26,485^{footnote F1}

$43.92

$1.16M

Feb 15, 2026

Dana Aftab - Officer

Tax withholding / forfeiture

Common Stock

12,720^{footnote F3}

$43.92

$559K

Footnote F1 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January… Full note on SEC EDGAR
Footnote F3 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of RSUs awarded on January 5, 2023.

Feb 13, 2026

Bob Oliver - Director

Option exercise

Common Stock

9,088

$19.28

$175K

Feb 13, 2026

Bob Oliver - Director

Open-market sale

Common Stock

9,088

$43.61

$396K

Feb 13, 2026

Bob Oliver - Director

Open-market sale

Common Stock

21,162

$43.90^{footnote F2}

$929K

Feb 13, 2026

Bob Oliver - Director

Option exercise

Option (right to buy)

9,088

$0.00

Footnote F2 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.90 to $43.96. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR

Feb 15, 2026

Brenda Hefti - Officer

Tax withholding / forfeiture

Common Stock

5,430^{footnote F1}

$43.92

$238K

Feb 18, 2026

Brenda Hefti - Officer

Open-market sale

Common Stock

18,669

$44.01^{footnote F4}

$822K

Footnote F1 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January… Full note on SEC EDGAR
Footnote F4 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.32 to $44.49. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR

Jan 15, 2026

Michael Morrissey - Officer

Grant or award

Common Stock

548,073^{footnote F2}

$0.00

Jan 15, 2026

Michael Morrissey - Officer

Tax withholding / forfeiture

Common Stock

139,524^{footnote F4}

$45.23

$6.31M

Footnote F2 (shares): On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's… Full note on SEC EDGAR
Footnote F4 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026.

Jan 15, 2026

Dana Aftab - Officer

Grant or award

Common Stock

119,578^{footnote F2}

$0.00

Jan 15, 2026

Dana Aftab - Officer

Tax withholding / forfeiture

Common Stock

27,254^{footnote F4}

$45.23

$1.23M

Footnote F2 (shares): On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's… Full note on SEC EDGAR
Footnote F4 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026.

Jan 15, 2026

Patrick J. Haley - Officer

Grant or award

Common Stock

139,508^{footnote F2}

$0.00

Jan 15, 2026

Patrick J. Haley - Officer

Tax withholding / forfeiture

Common Stock

32,332^{footnote F4}

$45.23

$1.46M

Footnote F2 (shares): On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's… Full note on SEC EDGAR
Footnote F4 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026.

Jan 15, 2026

Christopher J. Senner - Officer

Grant or award

Common Stock

149,474^{footnote F2}

$0.00

Jan 15, 2026

Christopher J. Senner - Officer

Tax withholding / forfeiture

Common Stock

40,459^{footnote F4}

$45.23

$1.83M

Footnote F2 (shares): On January 15, 2026, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 175% of the Target Shares subject to the PSU (such shares, the "Achieved Shares"). Accordingly, the Committee's… Full note on SEC EDGAR
Footnote F4 (shares): Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of the PSUs awarded on April 3, 2023, for which the Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 15, 2026.

Nov 25, 2025

David Edward Johnson - Director

Open-market purchase

Common Stock

27,532

$43.12

$1.19M

Nov 20, 2025

Patrick J. Haley - Officer

Open-market sale

Common Stock

10,000

$42.11^{footnote F1}

$421K

Nov 20, 2025

Patrick J. Haley - Officer

Open-market sale

Common Stock

23,539

$41.93^{footnote F3}

$987K

Nov 20, 2025

Patrick J. Haley - Officer

Open-market sale

Common Stock

10,648

$41.77^{footnote F4}

$445K

Nov 21, 2025

Patrick J. Haley - Officer

Open-market sale

Common Stock

28,043

$42.58^{footnote F5}

$1.19M

Footnote F1 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.10 to $42.13. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F3 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.87 to $41.99. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F4 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.77 to $41.79. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F5 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.51 to $42.71. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR

Nov 21, 2025

Dana Aftab - Officer

Gift

Common Stock

24,000

$0.00

Nov 17, 2025

Bob Oliver - Director

Gift

Common Stock

1,044

$0.00

Nov 12, 2025

Stelios Papadopoulos - Director

Open-market sale

Common Stock

100,000

$43.55^{footnote F1}

$4.36M

Footnote F1 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.55 to $43.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR

Nov 11, 2025

Michael Morrissey - Officer

Gift

Common Stock

160,000

$0.00

Nov 12, 2025

Michael Morrissey - Officer

Gift

Common Stock

101,548

$0.00

Nov 12, 2025

Michael Morrissey - Officer

Gift

Common Stock

101,548

$0.00

Nov 12, 2025

Michael Morrissey - Officer

Gift

Common Stock

80,000

$0.00

Nov 11, 2025

Dana Aftab - Officer

Open-market sale

Common Stock

48,383

$42.50^{footnote F1}

$2.06M

Footnote F1 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR

Nov 11, 2025

Mary C. Beckerle - Director

Option exercise

Option (right to buy)

5,784

$0.00

Nov 11, 2025

Mary C. Beckerle - Director

Option exercise

Common Stock

5,784

$23.24

$134K

Nov 11, 2025

Mary C. Beckerle - Director

Open-market sale

Common Stock

5,784

$42.03

$243K

Nov 11, 2025

Mary C. Beckerle - Director

Open-market sale

Common Stock

18,838

$41.90^{footnote F2}

$789K

Footnote F2 (price): Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.81 to $42.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange… Full note on SEC EDGAR

Oct 8, 2025

Dana Aftab - Officer

Grant or award

Common Stock

50,673^{footnote F1}

$0.00

Footnote F1 (shares): Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity… Full note on SEC EDGAR

Jun 3, 2025

Jack L. Wyszomierski - Director

Open-market sale

Common Stock

7,535

$43.09

$325K

May 29, 2025

Stelios Papadopoulos - Director

Grant or award

Common Stock

9,812

$0.00

May 29, 2025

George Poste - Director

Grant or award

Common Stock

9,812

$0.00

May 29, 2025

Jack L. Wyszomierski - Director

Grant or award

Common Stock

9,812

$0.00

May 16, 2025

George Poste - Director

Option exercise

Common Stock

20,634

$19.77

$408K

May 16, 2025

George Poste - Director

Open-market sale

Common Stock

20,634

$45.99

$949K

May 16, 2025

George Poste - Director

Option exercise

Option (right to buy)

20,634

$0.00

May 15, 2025

Stelios Papadopoulos - Director

Option exercise

Common Stock

20,634

$19.77

$408K

May 15, 2025

Stelios Papadopoulos - Director

Open-market sale

Common Stock

20,634

$44.35

$915K

May 15, 2025

Stelios Papadopoulos - Director

Option exercise

Common Stock

15,874

$20.50

$325K

May 15, 2025

Stelios Papadopoulos - Director

Open-market sale

Common Stock

15,874

$44.35

$704K

May 15, 2025

Stelios Papadopoulos - Director

Option exercise

Option (right to buy)

20,634

$0.00

May 15, 2025

Stelios Papadopoulos - Director

Option exercise

Option (right to buy)

15,874

$0.00

May 14, 2025

Michael Morrissey - Officer

Option exercise

Common Stock

308,365

$18.80

$5.80M

May 14, 2025

Michael Morrissey - Officer

Tax withholding / forfeiture

Common Stock

220,494

$44.65

$9.85M

May 15, 2025

Michael Morrissey - Officer

Tax withholding / forfeiture

Common Stock

104,769

$44.65

$4.68M

May 16, 2025

Michael Morrissey - Officer

Gift

Common Stock

87,871

$0.00

May 16, 2025

Michael Morrissey - Officer

Gift

Common Stock

87,871

$0.00

May 14, 2025

Michael Morrissey - Officer

Option exercise

Option (right to buy)

308,365

$0.00

Filed

Filer

Relationship

Market value

Notice

Aug 10, 2026

MARY BECKERLE

Director

9,812

$526K

View on EDGAR

Jun 1, 2026